A new super-vaccine with the ability to eliminate all 90 known strains of the world’s most deadly bacterial disease is being developed.

G-PN is a whole cell pneumococcal vaccine that is inactivated by exposure to gamma irradiation.

It was developed by researchers from the University of Adelaide in South Australia and is capable of preventing disease caused by all serotypes of pneumococcus (Streptococcus pneumoniae).

Lead researcher James Paton said G-PN would help to increase immune responses to pneumococcus because it kept the antigenic structure of protein surfaces on the bacterium.

Read more

Related Articles